Omni Health Stock Market Outlook

Stocks . USA . 
Stock . Omni Health
OMHE Stock  USD 0.00003  0.00  0.00%   
This sentiment measure is descriptive rather than personalized advice and should be used with other evidence before acting on it. Around 56% of recent sentiment around Omni Health has been mildly defensive over the recent sample. Taken on its own, that leaves the current sentiment reading for Omni Health close to neutral at this time.
Investor Comfort Level
PanicConfidence
44 · Impartial

Elasticity to Hype and News Sentiment

Omni Health news coverage registers mixed at 50%, a data point that gauges whether public narrative is leading or lagging the business reality. Comparing perception data with actual financial results can separate headline-driven pressure from genuine fundamental change.
Given a 90-day horizon, with a moderate risk tolerance, the model output for Omni Health is 'Strong Sell'. The Omni Health buy-or-sell recommendation is derived from the selected investment horizon and risk tolerance parameters for Omni Health.
  

Run Omni Health Outlook Model

Our Omni Health outlook engine provides a data-driven supplement to the analyst consensus on Omni Health. Macroaxis has no vested interest in Omni Health or any other instrument analyzed here. Multiple quantitative inputs drive the Omni Health's signal across different market conditions.

How This Model Works

The recommendation output for Omni Health is a model-based view that converts the selected horizon and risk profile into a standardized reading of the current evidence.

  • Inputs - valuation signals, price behavior, volatility, liquidity, sentiment, and analyst coverage when available
  • Current setup - Three Months with a risk setting described as I am an average risk taker
  • Limits - the model does not account for taxes, outside holdings, concentration constraints, or investor-specific mandates

Use the output as structured decision support and pair it with your own research, portfolio context, and any professional advice you rely on.

Time Horizon

Risk Tolerance

Update Outlook
SellBuy
Hold
Not Rated
For the selected horizon, Omni Health yields Operating Margin TTM of -0.0337, Current Valuation of 292.91 K, and Shares Outstanding of 976.38 M, which produce a balanced but non-directional signal.
This model-based assessment for Omni Health combines fundamental quality metrics with price behavior and the current analyst outlook to produce an integrated outlook. For additional context on this micro-cap stock in the Consumer Staples sector, analyze the full set of Omni Health reported fundamentals, including the relationship between the market capitalization ttm and current asset ttm. As Omni Health appears to be a penny stock, its debt to equity ttm numbers are an important reference point for this model output.

Recent Events and Market Context

The events below reflect recent headlines associated with Omni Health. Not all items directly affect the outlook — they are included to show the broader information environment that can shape sentiment and trading behavior.
Backtest Omni Health

Key Drivers of Volatility and Market Exposure

Like most traded instruments, Omni Health reflects both market risk and company or sector-specific developments. Diversifying across uncorrelated assets may reduce specific volatility, but broader stock market fluctuations remain influential. Omni Health is a public company tracked for its key financial metrics in the Consumer Staples sector.
α
Alpha over Dow Jones		0.00
β
Beta against Dow Jones0.00
σ
Overall volatility		0.00
Ir
Information ratio 0.00
Omni Health return patterns indicate measurable variability compared to typical market movement.

Fundamentals Vs Peers

Omni Health is measured here against stocks with similar revenue scale, margin profile, and capital structure. The comparison below reveals whether Omni Health generates superior or inferior returns relative to similar stocks. Divergence between Omni Health's valuation multiples and its peer group flags either mispricing or a structural difference in quality.
    
 Better Than Average     
    
 Worse Than Average Compare Omni Health to competition
FundamentalsOmni HealthPeer Average
Operating Margin TTM-0.0337-5.51
Current Valuation292.91 K16.62 billion
Shares Outstanding976.38 M571.82 million
Price To Earnings TTM5.17 X28.72 X
Price To Book TTM0.21 X9.51 X
Price To Sales TTM0.17 X11.42 X
Revenue TTM4.7 M9.43 billion
Net Income TTM1.27 M570.98 million
Cash And Equivalents TTM7.65 K2.7 billion
Total Debt TTM1.35 M5.32 billion
Debt To Equity TTM0.47 %48.70 %
Book Value Per Share TTM0.003 X1,931
Cash Flow From Operations TTM-42.49 K971.22 million
Trailing Beta0.01-0.15
Market Capitalization TTM29.29 K19.03 billion
Total Asset TTM5.53 M29.47 billion
Retained Earnings TTM691.54 K9.33 billion
Working Capital TTM-134 K1.48 billion
Current Asset TTM56 K9.34 billion
Current Liabilities TTM190 K7.9 billion
Net Asset5.53 MN/A

Recommendation Framework, Assumptions & Editorial Oversight

The model output for Omni Health reflects the current horizon and risk settings, refreshes as underlying data changes, and is intended to organize evidence rather than replace investor judgment. Current model inputs for Omni Health include P/E of 5.17, market cap of 29,291.

Reported values for Omni Health are derived from periodic company reporting and market reference feeds and standardized for analysis. The model combines valuation, price behavior, volatility, and sentiment into a standardized quantitative view.

Editorial Review & Methodology Oversight

Raphi Shpitalnik
Role: Junior Member of Macroaxis Editorial Board
Finance background: Raphael is a young entrepreneur who joined Macroaxis on a part-time basis at the beginning of the pandemic and eventually acquired a real taste for investing and fintech. He likes to analyze different equity instruments across a wide range of industries, focusing primarily on consumer products, sports, fintech, cannabis, and AI.
Oversight scope: Reviews recommendation-framework framing, source assumptions, and disclosure language.
Last reviewed on May 5th, 2026

Tools
Analysis
Directory
Company
2026 Macroaxis LLC Made with in San Francisco
Privacy Terms Widgets Feedback
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and conditions page.